Interestingly in support of this, the majority of PIK3CA-mutant thyroid cancer cell lines tested did not exhibit an increase in apoptosis in response to combined inhibition of Src and the MAPK pathway. This evidence concerns the gene PIK3CA and thyroid cancer.